Bank of Montreal
KRYS icon

Bank of Montreal’s Krystal Biotech KRYS Stock Holding History

Bank of Montreal’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-14,700
Closed -$624K – 4854
2020
Q2 		$624K Buy
+14,700
New +$707K ﹤0.01% 2147

Other funds holding KRYS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of Montreal's KRYS Position: Q2 2026 in Review

Bank of Montreal increased its Krystal Biotech (KRYS) stake by 4.1% in Q2 2026, buying an estimated $38.5K and bringing the position to 3,291 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1978.

Bank of Montreal first reported a position in KRYS in Q2 2019 and has held it in 18 quarters since. The position peaked at $1.76M in Q4 2022. 272 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Bank of Montreal held 3,291 shares of Krystal Biotech worth $1.22M as of Q2 2026.
  • Bank of Montreal bought 129 Krystal Biotech shares in Q2 2026, an estimated $38.5K.
  • Krystal Biotech made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1978 holding.
  • Bank of Montreal first reported a position in Krystal Biotech in Q2 2019 and has held it in 18 quarters since.
  • Bank of Montreal's Krystal Biotech position peaked at $1.76M in Q4 2022.
  • 272 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.